Gregory Katz
About Gregory Katz
Gregory Katz is a Senior Director at IntegriChain, with extensive experience in pricing and contracts management in the pharmaceutical industry. He has held various positions at companies such as Lundbeck, Takeda, and Abbott over a career spanning several decades.
Current Role at IntegriChain
Gregory Katz serves as Senior Director at IntegriChain, a position he has held since 2020. In this role, he focuses on strategic initiatives and operational management within the organization. His experience in pricing and contract administration informs his contributions to the company's objectives in the Greater Chicago Area.
Previous Experience at Lundbeck
Katz worked at Lundbeck from 2009 to 2019, where he held multiple roles including Associate Director of Contracts & Pricing and Senior Manager of Managed Care Contracts and Government Reporting. His tenure at Lundbeck spanned six years, during which he developed expertise in pricing strategies and contract negotiations in the pharmaceutical industry.
Career Background in Contract Administration
Gregory Katz has extensive experience in contract administration, having worked at Takeda in various capacities from 2004 to 2009. His roles included Manager of Commercial Pricing Administration and Manager of Contract Administration. This background has equipped him with a strong understanding of pricing operations and contract management processes.
Educational Background
Katz holds a Bachelor of Science in Accounting from Robert Morris University and an MBA in Finance from DePaul University - Charles H. Kellstadt Graduate School of Business. His educational qualifications provide a solid foundation for his career in finance and pricing operations.
Experience at Abbott
Gregory Katz has a significant history with Abbott, where he held several positions from 1996 to 2004. His roles included Pricing Analyst, Senior Pricing Analyst, Manager of Pricing Operations, and Supervisor of Financial Analysis. This experience contributed to his expertise in pricing strategies within the healthcare sector.